Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion description "[Current therapy of haemophilia is based on factor VIII (FVIII) or factor IX (FIX) replacement therapy including prophylactic or demand protocols of fixed-dose, and as future alternative, gene and cell therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion evidence source_evidence_literature NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion SIO_000772 21396685 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion wasDerivedFrom befree-20150227 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion wasGeneratedBy ECO_0000203 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- befree-20150227 importedOn "2015-02-27" NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.